Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Merit Medical Sys (MMSI)

Merit Medical Sys (MMSI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,340,870
  • Shares Outstanding, K 55,484
  • Annual Sales, $ 994,850 K
  • Annual Income, $ 5,450 K
  • 60-Month Beta 1.05
  • Price/Sales 2.37
  • Price/Cash Flow 12.53
  • Price/Book 2.53

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate 0.19
  • Number of Estimates 5
  • High Estimate 0.23
  • Low Estimate 0.13
  • Prior Year 0.28
  • Growth Rate Est. (year over year) -32.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
40.67 unch
on 09/21/20
50.38 -19.27%
on 09/09/20
-7.17 (-14.99%)
since 08/21/20
3-Month
40.50 +0.42%
on 07/13/20
50.38 -19.27%
on 09/09/20
-1.52 (-3.60%)
since 06/19/20
52-Week
19.50 +108.56%
on 10/31/19
50.38 -19.27%
on 09/09/20
+10.42 (+34.45%)
since 09/20/19

Most Recent Stories

More News
DexCom Introduces Registry to Monitor Outcomes of G6 System

DexCom (DXCM) sets up registry to track outcomes of patients and healthcare professionals using CGM in hospitals.

DXCM : 389.10 (-0.05%)
SRDX : 38.47 (+1.29%)
MMSI : 40.30 (-4.48%)
OPK : 3.28 (+3.47%)
Here's Why You Should Retain Avanos Medical Stock for Now

Investor confidence is high on Avanos Medical (AVNS), thanks to solid prospects.

SRDX : 38.47 (+1.29%)
MMSI : 40.30 (-4.48%)
OPK : 3.28 (+3.47%)
AVNS : 33.02 (-2.45%)
Here's Why You Should Add Surmodics to Your Portfolio Now

Investor confidence is high on Surmodics (SRDX) stock, thanks to solid prospects.

SRDX : 38.47 (+1.29%)
MMSI : 40.30 (-4.48%)
OPK : 3.28 (+3.47%)
NXGN : 12.50 (-4.36%)
Here's Why You Should Retain Allscripts (MDRX) Stock for Now

Investor confidence is high on Allscripts (MDRX) stock, thanks to solid prospects.

MDRX : 7.88 (-3.43%)
SRDX : 38.47 (+1.29%)
MMSI : 40.30 (-4.48%)
OPK : 3.28 (+3.47%)
Uptrend Call Working As Merit Medical Stock Rises 32.9% (MMSI)

SmarTrend identified an Uptrend for Merit Medical (NASDAQ:MMSI) on March 26th, 2020 at $34.23. In approximately 6 months, Merit Medical has returned 32.91% as of today's recent price of $45.49.

MMSI : 40.30 (-4.48%)
Here's Why You Should Add DaVita (DVA) to Your Portfolio Now

Investor confidence is high on DaVita (DVA) stock, thanks to solid prospects.

DVA : 83.63 (-4.23%)
SRDX : 38.47 (+1.29%)
MMSI : 40.30 (-4.48%)
OPK : 3.28 (+3.47%)
Here's Why You Should Hold on to CONMED (CNMD) Stock for Now

Investor confidence is high on CONMED (CNMD) stock, thanks to solid prospects.

CNMD : 70.33 (-9.40%)
SRDX : 38.47 (+1.29%)
MMSI : 40.30 (-4.48%)
OPK : 3.28 (+3.47%)
Merit Medical Up 42.5% Since SmarTrend Uptrend Call (MMSI)

SmarTrend identified an Uptrend for Merit Medical (NASDAQ:MMSI) on March 26th, 2020 at $34.23. In approximately 5 months, Merit Medical has returned 42.50% as of today's recent price of $48.77.

MMSI : 40.30 (-4.48%)
OPKO Health's BioReference Laboratories Introduces NGS Assay

OPKO Health's (OPK) OnkoSight Advanced is a NGS assay that facilitates revolutionary DNA mutational profiling of tumor samples.

SRDX : 38.47 (+1.29%)
MMSI : 40.30 (-4.48%)
OPK : 3.28 (+3.47%)
NXGN : 12.50 (-4.36%)
Merit Medical to Participate at Four Conferences in September

Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology,...

MMSI : 40.30 (-4.48%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Trade MMSI with:

Business Summary

Merit Medical Systems, Inc. set out to build the world's most customer-focused healthcare company by understanding customers' needs, and innovating and delivering a diverse range of products that improve the lives of people, families, and communities throughout the world. Merit's primary products consist...

See More

Key Turning Points

2nd Resistance Point 44.44
1st Resistance Point 43.31
Last Price 40.30
1st Support Level 41.42
2nd Support Level 40.65

See More

52-Week High 50.38
Last Price 40.30
Fibonacci 61.8% 38.58
Fibonacci 50% 34.94
Fibonacci 38.2% 31.30
52-Week Low 19.50

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar